FDA Approved: INJECTAFER — Supplemental Application (American Regent, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Injectafer (ferric carboxymaltose injection) filed by American Regent, Inc. The submission status is AP.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia

Drugs mentioned

• INJECTAFER (ferric carboxymaltose injection)

Snippet

SUPPL AP for INJECTAFER (FERRIC CARBOXYMALTOSE INJECTION)